Intracameral Cefuroxime in the Prevention of Postoperative Endophthalmitis: an Experience from Hong Kong

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2016 Aug 25

PMID 27553051

Citations 10

Authors

Alex Lap-Ki Ng

Wilson Wai-Tat Tang

Patrick Siu-Hung Li

Kenneth Kai-Wang Li

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose was to study the effect of introducing intracameral cefuroxime, which was compounded by a hospital pharmacy, on postoperative endophthalmitis in a tertiary eye centre in Hong Kong.

Methods: All cases that underwent cataract surgeries over a 12-year period (January 2004 to December 2015) were included. The routine use of intracameral cefuroxime at the end of cataract surgery was introduced at our centre after April 2010. All cefuroxime aliquots were prepared by the hospital pharmacy using an aseptic compounding technique. The rates of postoperative endophthalmitis before April 2010 (Group 1, no intracameral cefuroxime) and after April 2010 (Group 2, routine use of intracameral cefuroxime) were compared.

Results: A total of 30,428 eyes (7,332 in Group 1 and 23,096 in Group 2) were studied. Eight cases developed postoperative endophthalmitis (1.09 in 1000; 0.11 %) in Group 1 whereas no cases developed endophthalmitis (0 %) in Group 2. The rate of reduction was statistically significant (p < 0.0001). Seven out of eight cases of endophthalmitis were confirmed by positive culture. Organisms identified were Group G Streptococcus (two cases), Group B Streptococcus, Staphylococcus aureus, Serratia marcescens, and coagulase-negative Staphylococcus (two cases). Antibiotic susceptibility testing results were available in six cases. Four out of six organisms were susceptible to the penicillin group. No adverse events related to the use of intracameral cefuroxime were encountered.

Conclusions: The use of intracameral cefuroxime could significantly reduce the rate of postoperative endophthalmitis in a tertiary centre in Hong Kong. The use of aseptic compounding to prepare cefuroxime aliquots by hospital pharmacy appeared to be safe and efficacious.

Citing Articles

Visual and Refractive Outcomes after Phacoemulsification Cataract Surgery in Nanophthalmic Eyes.

Lai T, Tse J, Chan J, Li K J Clin Med. 2024; 13(19).

PMID: 39407912 PMC: 11477411. DOI: 10.3390/jcm13195852.

A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime.

Jiang C, Zheng X, Li P, Qian J, Li Q Ther Adv Drug Saf. 2024; 15:20420986241258049.

PMID: 38881538 PMC: 11177735. DOI: 10.1177/20420986241258049.

Susceptibility of Ocular Surface Bacteria to Various Antibiotic Agents in a Romanian Ophthalmology Clinic.

Ghita A, Iliescu D, Ghita A, Ilie L Diagnostics (Basel). 2023; 13(22).

PMID: 37998545 PMC: 10670825. DOI: 10.3390/diagnostics13223409.

A survey of Asian Eye Institutions on perioperative antibiotic prophylaxis in cataract surgery.

Garg P, Khor W, Roy A, Tan D Int Ophthalmol. 2023; 43(11):4151-4162.

PMID: 37526782 PMC: 10520096. DOI: 10.1007/s10792-023-02816-w.

Intraoperative Cefuroxime Irrigation Prophylaxis for Acute-Onset Endophthalmitis After Phacoemulsification Surgery.

Ma X, Xie L, Huang Y Infect Drug Resist. 2020; 13:1455-1463.

PMID: 32547114 PMC: 7244738. DOI: 10.2147/IDR.S252674.

References

Meyer J, Polkinghorne P, McGhee C . Cataract surgery practices and endophthalmitis prophylaxis by New Zealand Ophthalmologists. Clin Exp Ophthalmol. 2016; 44(7):643-645. DOI: 10.1111/ceo.12712. View

Behndig A, Cochener-Lamard B, Guell J, Kodjikian L, Mencucci R, Nuijts R . Surgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European Observatory in 2013. J Cataract Refract Surg. 2016; 41(12):2635-43. DOI: 10.1016/j.jcrs.2015.06.031. View

Delyfer M, Rougier M, Leoni S, Zhang Q, Dalbon F, Colin J . Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg. 2011; 37(2):271-8. DOI: 10.1016/j.jcrs.2010.08.047. View

Gore D, Angunawela R, Little B . United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study. J Cataract Refract Surg. 2009; 35(4):770-3. DOI: 10.1016/j.jcrs.2009.01.004. View

Herrinton L, Shorstein N, Paschal J, Liu L, Contreras R, Winthrop K . Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery. Ophthalmology. 2015; 123(2):287-294. PMC: 5531863. DOI: 10.1016/j.ophtha.2015.08.039. View

Garat M, Moser C, Martin-Baranera M, Alonso-Tarres C, Alvarez-Rubio L . Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year study. J Cataract Refract Surg. 2009; 35(4):637-42. DOI: 10.1016/j.jcrs.2008.12.023. View

Villada J, Vicente U, Javaloy J, Alio J . Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery. J Cataract Refract Surg. 2005; 31(3):620-1. DOI: 10.1016/j.jcrs.2004.06.086. View

Chang D, Braga-Mele R, Henderson B, Mamalis N, Vasavada A . Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015; 41(6):1300-5. DOI: 10.1016/j.jcrs.2015.01.014. View

Barreau G, Mounier M, Marin B, Adenis J, Robert P . Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. J Cataract Refract Surg. 2012; 38(8):1370-5. DOI: 10.1016/j.jcrs.2012.03.024. View

10.

Grosso A, Pertile G, Marchini G, Scarpa G, Ceruti P, Prigione G . Adherence to European Society for Cataract and Refractive Surgery recommendations among Italian cataract surgeons: a survey. Eur J Ophthalmol. 2016; 26(5):398-404. DOI: 10.5301/ejo.5000738. View

11.

. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007; 33(6):978-88. DOI: 10.1016/j.jcrs.2007.02.032. View

12.

Garcia-Saenz M, Arias-Puente A, Rodriguez-Caravaca G, Banuelos J . Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study. J Cataract Refract Surg. 2010; 36(2):203-7. DOI: 10.1016/j.jcrs.2009.08.023. View

13.

Rodriguez-Caravaca G, Garcia-Saenz M, Villar-Del-Campo M, Andres-Alba Y, Arias-Puente A . Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery. J Cataract Refract Surg. 2013; 39(9):1399-403. DOI: 10.1016/j.jcrs.2013.03.031. View

14.

Moisseiev E, Levinger E . Anaphylactic reaction following intracameral cefuroxime injection during cataract surgery. J Cataract Refract Surg. 2013; 39(9):1432-4. DOI: 10.1016/j.jcrs.2013.06.008. View

15.

Bodnar Z, Clouser S, Mamalis N . Toxic anterior segment syndrome: Update on the most common causes. J Cataract Refract Surg. 2012; 38(11):1902-10. DOI: 10.1016/j.jcrs.2012.06.053. View

16.

Shorstein N, Winthrop K, Herrinton L . Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2012; 39(1):8-14. DOI: 10.1016/j.jcrs.2012.07.031. View

17.

Behndig A, Cochener B, Guell J, Kodjikian L, Mencucci R, Nuijts R . Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013; 39(9):1421-31. DOI: 10.1016/j.jcrs.2013.06.014. View

18.

Katz G, Blum S, Leeva O, Axer-Siegel R, Moisseiev J, Tesler G . Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience. Graefes Arch Clin Exp Ophthalmol. 2015; 253(10):1729-33. DOI: 10.1007/s00417-015-3009-z. View

19.

Friling E, Lundstrom M, Stenevi U, Montan P . Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2012; 39(1):15-21. DOI: 10.1016/j.jcrs.2012.10.037. View

20.

Barry P . Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. J Cataract Refract Surg. 2013; 40(1):138-42. DOI: 10.1016/j.jcrs.2013.11.002. View